Sera from 680 non
Introduction
Over the past 20 years numerous reports claim to have identified autoantibodies against insulin,1-4 but in most either the specificity of the assay, the exact nature of the binding factor, or insulin naivety in the subjects has been in doubt. 5 While the antibodies against commercial insulin commonly found in the sera of diabetics are usually of minor clinical importance, those arising spontaneously might be of greater potential interest as markers for autoimmunity, analogous to the thyroglobulin antibodies in thyroiditis and antibodies against intrinsic factor in gastritis. Autoimmune disorders tend to cluster within individuals,6 so that the search for insulin autoantibodies might logically be concentrated on people already subject to autoimmunity. We have therefore looked for antibodies against insulin in the sera of a large number of patients with autoimmune diathesis.
Subjects and methods
We examined sera from 680 consecutive non-diabetic patients (238 men, 442 women; mean age 53 (SD 28) years) with suspected autoimmune disease referred to the autoimmune profile laboratory in our department. Tests included in the profile were for antibodies against thyroid microsomes, thyroglobulin, gastric parietal cells, renal glomerular basement membrane, striated muscle, smooth muscle, mitochondria, reticulin, keratin, nuclear factor, DNA, skin, and rheumatoid factor. Based on the results the patients were divided into 582 subjects who were found to have one or more of these antibodies (group 1) and 98 subjects found not to have any of them (group 2). We also studied the sera from a control group of 94 healthy adults (mean age 38 (SD 7) years) with no history or suspicion of autoimmune disease (group 3), 31 randomly selected non-insulin dependent diabetics (mean age 64 (SD 11) years), and 19 insulin dependent diabetics (mean age 57 (SD 17) years).
ASSAY
We devised an enzyme linked immunosorbent microassay7 similar to the system for measuring thyroglobulin antibodies. 8 Human insulin added in displacement studies.
-----Porcine insulin added in displacement studies.. 
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.Diabetics- Figure 2 shows the results of insulin binding by sera from the non-insulin dependent and insulin dependent diabetics.
Binding was less than 5% in 28 of the 31 non-insulin dependent diabetics and less than 6% in all of them. Of the 19 insulin dependent diabetics, 11 showed binding greater than 5%, the strongest (100%) <5  <5  <5  <5  <5  <5  <5  <5  <5  <5  <5  <5  (  <5  <5  <5  <5  <5  <5  <5  <5  <5  <5  <5  <5 DISPLACEMENT STUDIES Attempts to inhibit antibody binding imnmunospecifically were made by adding increasing amounts of "cold" insulin of different species to the incubation mixture so as to obtain final concentrations of 0-1000 U/l. Figure 3 shows the displacemrnt patterns observed and In the present series, however, none of the nine patients with insulin antibodies was diabetic, all denied contact with insulin, and none had antibodies against animal C peptide. The assay used did not employ an iodinated ligand and it identified immunoglobulins immunospecifically, effectively ruling out interference from non-immunoglobulin binding factors. The detection of antibodies exclusively against human insulin in sera which were drawn before human insulin was available in Britain tends to remove suspicion of its self administration. Furthermore, all nine patients had independent evidence of autoimmunity, and insulin antibodies were not found in the sera of normal controls, non-insulin dependent diabetics, or patients suspected of autoimmune disease who turned out to be seronegative in tests for their autoimmune profile. Autoimmunity to insulin therefore appears to exist only in the context of polyautoimmunity.
This report points strongly towards the existence of autoimmunity to insulin and suggests that the response may be specific for human insulin. Human insulin differs from porcine by a single amino acid substitution, so that a response exclusive to human insulin implies autoantibodies of considerable homogeneity directed against a very limited number of antigenic sites (epitopes). Three important questions arise: How restricted is the clonal response in insulin autoimmunity-might the antibodies be monotypic or even monoclonal ? Out of all the possible antigenic sites on an insulin molecule, why is the autoimmune response in more than half of the sera directed against the single or very limited number of epitopes unique to human insulin ? Put alternatively, why-apparently against all laws of chance-is the immunoreactive epitope in these responses also the species defining epitope ? Finally, what are the clinical implications of our findings ?
We are currently studying the clonality of insulin autoantibodies, but it is interesting to note that the autoantibodies found in patients with systemic lupus erythematosus are not only clonally restricted,'2 but also share the same idiotypes (antigen binding shapes) with unrelated sufferers from the disorder."3 Whether the epitopes against which these antibodies respond show evidence of species restriction, similar to that which we have shown in insulin autoimmunity, is unknown.
The trigger for insulin autoantibodies and their role, if any, in the pathogenesis of disease are also unknown, but recent data from virus infected animal models are intriguing. '4 15 For example, mice infected with passaged reovirus developed insulin dependent diabetes associated with the appearance of antibodies not only against cytoplasmic antigens within the islet cells but also against cell surface antigens and insulin.14 The response, furthermore, was polyendocrine, with antibodies against anterior pituitary cells, growth hormone, and thymocytes."5 The relation of this viral induced polyendocrine response in animals to the human polyendocrine syndromes, in which multiple autoantibodies are typical16 1 and from which our test sera were drawn, is likely to provide an area of intense and fruitful study. In reference to the loss of Woolveridge's Speculum Matricis, published in Dublin in 1670, and the earliest original work on midwifery written in the English language, we have learnt, since our article on the subject last week, the following particulars from Dr. Godson, who informs us that the person intrusted with the volume, for the purpose of copying it, has not been proved to have absconded with the volume. Dr. Fordyce Barker, in a letter to Dr. Godson, dated May 15th, 1883, gives a full account of the transaction. Dr. Barker possessed a copy of the book in question, and about five years ago, at the request of the Obstetrical Society of London, took steps to find a man who could make a copy of it for the Society. Two American librarians referred Dr. Barker to a well-known and learned dealer in old books, named Sabine, now deceased. Mr. Sabine recommended an eccentric Frenchman, who lived in constant penury, but was a good copyist, much employed by collectors in New York, London, Paris, and Rome. This man, whose name was Emile Bourgeaud, undertook to copy the specimen of Speculum Matricis, which was at once lent to him for the purpose by Dr. Barker, who could not get him to fix on any sum to be paid for his services. Dr. Barker lost sight of Bourgeaud for a long time, but in April, 1881, he brought back the book, repaired with great skill, but only a part of the copy. Starvation had evidently prevented him from completing his task. Dr. Barker has never seen since then this poor copyist, who took away the book once more to complete the copy. He wrote once to Dr. Barker, saying that he had been invited to Brazil by the Emperor, in order to do some work for the Imperial Library, but hoped to be back in New York by November, 1881, with the book completely copied. Bourgeaud never returned the work. Dr. Barker communicated with the United States Legation at Rio de Janeiro, and was informed that Bourgeaud had really been at work in the Imperial Library, and he had never asked for any remuneration, though his work had given great satisfaction. A steerage-passenger in a steamer which sailed from Rio in November, 1881, was entered in the ship's list as "A. Boojo." Dr. Barker then discovered that the ship's cook, a Frenchman, named Quinquinet, had taken great interest in this passenger. On landing in New York, he took his unhappy countryman, who was in very bad health, to a low French tavern in Worcester Street. In May, 1883, Dr. Barker found out this tavern, and discovered from the landlady that the sick Frenchman had brought with him a box, and asked for ink, but used to sit still in his room doing nothing, and his reckoning was only once paid, and then by some friend, who took him and his trunk away. This is the last news that Dr. Barker could obtain about poor Emile Bourgeaud. It is very unlikely that he destroyed either the original book or his copy, and it is to be hoped that it was found in the box by the friend, if Bourgeaud really died soon after leaving the French tavern, as appeared to be highly probable. If the friend and the box could be traced, the ultimate fate of the book may yet be known. Possibly some of our readers may find the missing work on this or on the other side of the Atlantic. (British Medical Journal 1884;i:426.)
